Indeed, high VRK1 expression shows a significant association with decreased relapse-free survival for patients with ER+ but not for ER- patients [31], indicating that VRK1 overexpression is correlated with poor prognosis in luminal breast cancers [32,33]. The gene discussed is VRK1; the disease is breast carcinoma.